A new survey says Americans’ confidence in their ability to afford a comfortable retirement remains at historically low levels in the face of job uncertainty and financial insecurity.
The 2012 annual Retirement Confidence Survey, released today by the nonpartisan Employee Benefit Research Institute (EBRI) in Washington, and co-sponsored by the Principal Financial Group, finds only 14 percent of Americans are very confident they will have enough money to live comfortably in retirement¹. Workers with the most debt have the least confidence.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54549-principal-financial-group-retirement-confidence-survey-job-insecurity-ebri
Express Scripts clinical innovations saved its clients $45 billion in 2018 and delivered a 25-year record low drug trend of just 0.4 percent across employer-sponsored plans, according to data released today in its annual Drug Trend Report, an authoritative analysis of drug spending in the U.S.
Express Scripts’ solutions for driving lower drug prices and fostering the use of lower-net-cost treatments are making medication more accessible for beneficiaries. Unit drug costs decreased in 2018 for employer-sponsored and Medicare plans, while utilization of medications rose.
To view the multimedia release go to:
https://www.multivu.com/players/English/8478051-express-scripts-2018-drug-trend-report/
http://www.youtube.com/watch?v=BD8S0QmMOuQ[EXTRACT]
http://RenegadeMillionaire.mobi You want more customers, but buyers are overly cautious because the media says the economy is hurting. Nonsense. Marketing legend, Dan Kennedy, has done the research for you, and shows how history proves NOW is your biggest opportunity to be crowned a millionaire. Forget what the majority of people are being led to believe, and get instant access to Dan's free, Renegade “Recession Made” Millionaire video series.
In the Renegade
The Federal Reserve on Tuesday began supplying financial institutions with a redesigned $100 note that incorporates new security features to deter counterfeiters and help businesses and consumers tell whether a note is genuine.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63665-federal-reserve-board-issues-redesigned-100-note
The following statement is being issued by Branstetter, Stranch & Jennings, PLLC regarding In re Prograf Antitrust Litigation.
A lawsuit is currently pending claiming that Astellas Pharma US, Inc. (“Astellas” or “Defendant”) violated state antitrust, unfair competition, consumer protection, and unjust enrichment laws of certain states by delaying the availability of a less expensive generic version of the immunosuppressant prescription drug Prograf® (known as tacrolimus). Plaintiffs allege that Defendant’s conduct caused some consumers and third party payors to pay too much for Prograf in certain states from September 3, 2008 to December 31, 2010 (also referred to as the “Class Damage Period”). This lawsuit does not claim that Prograf is unsafe or ineffective. Astellas denies any wrongdoing.
To view the multimedia release go to:
http://www.multivu.com/players/English/7933851-prograf-antitrust-class-action-settlement/
Ukraine’s PrivatBank has released a conceptual video showing how the bank’s mobile applications will be used in the nearest future after the launch of Google Glass.
The video shows how Google Glass will be used to pay bills by taking pictures of them, transfer money by giving voice commands, withdraw money or pay for purchases by reading QR codes, and even refuel.
PrivatBank explains that it has created numerous mobile applications which already can be used to do what is shown in the video.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/61903-privatbank-google-glass-mobile-app
